Radiolabeled Compounds for Diagnosis and Treatment of Cancer 

<br/><br/><br/>English[eng] 
<br/><br/><label>ISBN: </label>9783040000000 
<br/><br/><label>Subjects--Topical Terms: </label><br/>positron emission tomography (PET)||pyrazoles||fluorine-18||radionuclides||PET probes||imaging pharmaceuticals||hypopharyngeal cancer||188Re-liposome||repeated therapy||NGS||microRNA||aprepitant||radiopharmaceuticals||neurokinin 1 receptor antagonist||radionuclide chelators||kidney uptake||cleavable linkers||neutral endopeptidase (NEP)||renal brush border enzymes||prostate-specific membrane antigen (PSMA)||cancer imaging and therapy||somatostatin analogs||radiolabeling||radionuclide therapy||imaging||adrenergic receptor||positron emission tomography||radiotracer||cholecystokinin-2 receptor||minigastrin||molecular imaging||targeted radiotherapy||lutetium-177||EpCAM||radionuclide||SPECT||iodine||PIB||breast||cancer||PET||target-specific biomolecules||immunoPET imaging pharmaceuticals||production processes||124I-labeled monoclonal antibodies||radiotracers||AAZTA||scandium-44||FAP||SA||DPP||PREP||radioiodine labeling||radioiodination||biomolecules||peptides||proteins||monoclonal antibodies||123,124,125,131I-labeled molecules and biomolecules||n/a